XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional paid in capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Balances at Dec. 31, 2021 $ 764,298 $ 4 $ 928,095 $ (2,569) $ (161,232)
Balances (Shares) at Dec. 31, 2021   42,831      
Vesting of restricted stock units, net of tax (284)   (284)    
Vesting of restricted stock units, net of tax, shares   52      
Exercise of stock options, net of tax 337   337    
Exercise of stock options, net of tax, shares   76      
Issuance of common stock under employee stock purchase plan 622   622    
Issuance of common stock under employee stock purchase plan, shares   22      
Stock-based compensation expense 10,800   10,800    
Unrealized gain (loss) on available-for-sale securities, net (9,381)     (9,381)  
Net loss (76,723)       (76,723)
Balances at Mar. 31, 2022 689,669 $ 4 939,570 (11,950) (237,955)
Balances (Shares) at Mar. 31, 2022   42,982      
Balances at Dec. 31, 2022 516,195 $ 4 973,145 (15,401) (441,553)
Balances (Shares) at Dec. 31, 2022   43,299      
Vesting of restricted stock units, net of tax (419)   (419)    
Vesting of restricted stock units, net of tax, shares   99      
Exercise of stock options, net of tax 471   471    
Exercise of stock options, net of tax, shares   37      
Issuance of common stock under employee stock purchase plan 583   583    
Issuance of common stock under employee stock purchase plan, shares   30      
Stock-based compensation expense 11,206   11,206    
Unrealized gain (loss) on available-for-sale securities, net 3,779     3,779  
Net loss (66,676)       (66,676)
Balances at Mar. 31, 2023 $ 465,139 $ 4 $ 984,986 $ (11,622) $ (508,229)
Balances (Shares) at Mar. 31, 2023   43,465